CPP-ZFN: A potential DNA-targeting anti-malarial drug

Malaria Journal

Volumn 9, Issue 1, 2010, Pages

  Nain, Vikrant ^a   Sahi, Shakti ^a   Verma, Anju ^b  

^a GAUTAM BUDDHA UNIVERSITY   (India)

^b UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CELL PENETRATING PEPTIDE; CELL PENETRATING PEPTIDE PLUS ZINC FINGER NUCLEASE; NUCLEIC ACID; RNA; SIGNAL PEPTIDE; UNCLASSIFIED DRUG; VACCINE; ZINC FINGER NUCLEASE; ZINC FINGER PROTEIN; DEOXYRIBONUCLEASE; PROTOZOAL DNA;

CELL MEMBRANE; CELL NUCLEUS; CYTOPLASM; DNA SEQUENCE; DRUG DESIGN; DRUG MECHANISM; GENE TARGETING; GENOME; HUMAN; MALARIA; MITOCHONDRION; MULTIDRUG RESISTANCE; NONHUMAN; NOTE; PLASMODIUM; ZINC FINGER MOTIF; DRUG EFFECT; ENZYME SPECIFICITY; GENETICS; METABOLISM; PROTEIN BINDING; REVIEW;

ANTIMALARIALS; CELL MEMBRANE; DEOXYRIBONUCLEASES; DNA, PROTOZOAN; HUMANS; PLASMODIUM; PROTEIN BINDING; SUBSTRATE SPECIFICITY; ZINC FINGERS;

EID: 77956561675     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-9-258     Document Type: Note

References (76)

1. Current status of malaria and potential for control. RS Phillips, Clin Microbiol Rev 2001 14 208 226 10.1128/CMR.14.1.208-226.2001 11148010
2. The global fight against HIV/AIDS, tuberculosis, and malaria: current status and future perspectives. M Vitoria R Granich CF Gilks C Gunneberg M Hosseini W Were M Raviglione KM De Cock, Am J Clin Pathol 2009 131 844 848 10.1309/AJCP5XHDB1PNAEYT 19461091
3. African great apes are natural hosts of multiple related malaria species, including Plasmodium falciparum. F Prugnolle P Durand C Neel B Ollomo FJ Ayala C Arnathau L Etienne E Mpoudi-Ngole D Nkoghe E Leroy E Delaporte M Peeters F Renaud, Proc Natl Acad Sci USA 2010 107 1458 1463 10.1073/pnas.0914440107 20133889
4. Genome variation and evolution of the malaria parasite Plasmodium falciparum. DC Jeffares A Pain A Berry AV Cox J Stalker CE Ingle A Thomas MA Quail K Siebenthall AC Uhlemann S Kyes S Krishna C Newbold ET Dermitzakis M Berriman, Nat Genet 2007 39 120 125 10.1038/ng1931 17159978
5. The dynamics of mutations associated with anti-malarial drug resistance in Plasmodium falciparum. AA Escalante DL Smith Y Kim, Trends Parasitol 2009 25 557 563 10.1016/j.pt.2009.09.008 19864183
6. Global resistance surveillance: ensuring antimalarial efficacy in the future. PJ Guerin SJ Bates CH Sibley, Curr Opin Infect Dis 2009 22 593 600 10.1097/QCO.0b013e328332c4a7 19797946
7. Resistance to antimalarial compounds: methods and applications. B Witkowski A Berry F Benoit-Vical, Drug Resist Updat 2009 12 42 50 10.1016/j.drup.2009.01.001 19285915
8. Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia. MB Denis R Tsuyuoka P Lim N Lindegardh P Yi SN Top D Socheat T Fandeur A Annerberg EM Christophel P Ringwald, Trop Med Int Health 2006 11 1800 1807 10.1111/j.1365-3156.2006.01739.x 17176344 (Pubitemid 44813874)
9. Evidence of artemisinin-resistant malaria in western Cambodia. H Noedl Y Se K Schaecher BL Smith D Socheat MM Fukuda, NEJM 2008 359 2619 2620 10.1056/NEJMc0805011 19064625
10. Surveillance of the efficacy of artesunate and mefloquine combination for the treatment of uncomplicated falciparum malaria in Cambodia. MB Denis R Tsuyuoka Y Poravuth TS Narann S Seila C Lim S Incardona P Lim R Sem D Socheat EM Christophel P Ringwald, Trop Med Int Health 2006 11 1360 1366 10.1111/j.1365-3156.2006.01690.x 16930257 (Pubitemid 44289723)
11. Pfmdr1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border. AP Alker P Lim R Sem NK Shah P Yi DM Bouth R Tsuyuoka JD Maguire T Fandeur F Ariey C Wongsrichanalai SR Meshnick, Am J Trop Med Hyg 2007 76 641 647 17426163
12. Artemisinin resistance: current status and scenarios for containment. AM Dondorp S Yeung L White C Nguon NP Day D Socheat L von Seidlein, Nat Rev Microbiol 2010 8 272 280 10.1038/nrmicro2385 20208550
13. Genome sequence of the human malaria parasite Plasmodium falciparum. MJ Gardner N Hall E Fung O White M Berriman RW Hyman JM Carlton A Pain KE Nelson S Bowman IT Paulsen K James JA Eisen K Rutherford SL Salzberg A Craig S Kyes MS Chan V Nene SJ Shallom B Suh J Peterson S Angiuoli M Pertea J Allen J Selengut D Haft MW Mather AB Vaidya DM Martin AH Fairlamb MJ Fraunholz DS Roos SA Ralph GI McFadden LM Cummings GM Subramanian C Mungall JC Venter DJ Carucci SL Hoffman C Newbold RW Davis CM Fraser B Barrell, Nature 2002 419 498 511 10.1038/nature01097 12368864
14. Antimalarial versus Cytotoxic properties of dual drugs derived from 4-aminoquinolines and mannich bases: interaction with DNA. NI Wenzel N Chavain Y Wang W Friebolin L Maes B Pradines M Lanzer V Yardley R Brun C Herold-Mende C Biot K Toth E Davioud-Charvet, J Med Chem 2010 53 3214 3226 10.1021/jm9018383 20329733
15. Synthesis and activity of azaterphenyl diamidines against Trypanosoma brucei rhodesiense and Plasmodium falciparum. L Hu RK Arafa MA Ismail A Patel M Munde WD Wilson T Wenzler R Brun DW Boykin, Bioorg Med Chem 2009 17 6651 6658 10.1016/j.bmc.2009.07.080 19699098
16. Pharmacogenomic analyses of targeting the AT-rich malaria parasite genome with AT-specific alkylating drugs. JM Woynarowski M Krugliak H Ginsburg, Mol Biochem Parasitol 2007 154 70 81 10.1016/j.molbiopara.2007.04.009 17524501
17. Progress and prospects: zinc-finger nucleases as gene therapy agents. D Carroll, Gene Ther 2008 15 1463 1468 10.1038/gt.2008.145 18784746
18. "Magic" scissors for genome surgery. K Kandavelou M Mani S Durai S Chandrasegaran, Nat Biotechnol 2005 23 686 687 10.1038/nbt0605-686 15940239
19. Zinc-finger nucleases: the next generation emerges. T Cathomen JK Joung, Mol Ther 2008 16 1200 1207 10.1038/mt.2008.114 18545224
20. Targeted mutagenesis in zebrafish using customized zinc-finger nucleases. JE Foley ML Maeder J Pearlberg JK Joung RT Peterson JR Yeh, Nat Protoc 2009 4 1855 1867 10.1038/nprot.2009.209 20010934
21. Custom-designed molecular scissors for site-specific manipulation of the plant and mammalian genomes. K Kandavelou S Chandrasegaran, Methods Mol Biol 2009 544 617 636 full-text 19488728
22. Targeted genome editing in human cells with zinc finger nucleases constructed via modular assembly. HJ Kim HJ Lee H Kim SW Cho JS Kim, Genome Res 2009 19 1279 1288 10.1101/gr.089417.108 19470664
23. Targeted chromosomal deletions in human cells using zinc finger nucleases. HJ Lee E Kim JS Kim S Radecke F Radecke T Cathomen K Schwarz, Genome Res 2009 20 81 89 10.1101/gr.099747.109 19952142
24. Zinc-finger nucleases: a powerful tool for genetic engineering of animals. S Remy L Tesson S Menoret C Usal AM Scharenberg I Anegon Y Santiago E Chan PQ Liu S Orlando L Zhang FD Urnov MC Holmes D Guschin A Waite JC Miller EJ Rebar PD Gregory A Klug TN Collingwood J Wu K Kandavelou S Chandrasegaran M Mani K Kandavelou FJ Dy S Durai S Chandrasegaran, Transgenic Res 2009 26 26
25. Precise genome modification in the crop species Zea mays using zinc-finger nucleases. VK Shukla Y Doyon JC Miller RC DeKelver EA Moehle SE Worden JC Mitchell NL Arnold S Gopalan X Meng VM Choi JM Rock YY Wu GE Katibah G Zhifang D McCaskill MA Simpson B Blakeslee SA Greenwalt HJ Butler SJ Hinkley L Zhang EJ Rebar PD Gregory FD Urnov, Nature 2009 459 437 441 10.1038/nature07992 19404259
26. Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases. EE Perez J Wang JC Miller Y Jouvenot KA Kim O Liu N Wang G Lee VV Bartsevich YL Lee DY Guschin I Rupniewski AJ Waite C Carpenito RG Carroll JS Orange FD Urnov EJ Rebar D Ando PD Gregory JL Riley MC Holmes CH June, Nat Biotechnol 2008 26 808 816 10.1038/nbt1410 18587387
27. Intracellular transduction using cell-penetrating peptides. R Sawant V Torchilin H Raagel P Saalik M Pooga B Munst C Patsch F Edenhofer Y Gitton L Tibaldi E Dupont G Levi A Joliot F Edenhofer BR Meade SF Dowdy JM Gump SF Dowdy BR Meade SF Dowdy X Dong JN Wang YZ Huang LY Guo X Kong CL Murriel SF Dowdy, Mol Biosyst 2009 6 628 640 10.1039/b916297f 20237640
28. TAT transduction: the molecular mechanism and therapeutic prospects. JM Gump SF Dowdy BR Meade SF Dowdy X Dong JN Wang YZ Huang LY Guo X Kong CL Murriel SF Dowdy, Trends Mol Med 2007 13 443 448 10.1016/j.molmed.2007.08.002 17913584
29. Design of a bioactive cell-penetrating peptide: when a transduction domain does more than transduce. B Ward BL Seal CM Brophy A Panitch R Sawant V Torchilin H Raagel P Saalik M Pooga B Munst C Patsch F Edenhofer Y Gitton L Tibaldi E Dupont G Levi A Joliot F Edenhofer BR Meade SF Dowdy JM Gump SF Dowdy BR Meade SF Dowdy X Dong JN Wang YZ Huang LY Guo X Kong CL Murriel SF Dowdy, J Pept Sci 2009 15 668 674 10.1002/psc.1168 19691016
30. Efficient CPP-mediated Cre protein delivery to developing and adult CNS tissues. Y Gitton L Tibaldi E Dupont G Levi A Joliot F Edenhofer BR Meade SF Dowdy JM Gump SF Dowdy BR Meade SF Dowdy X Dong JN Wang YZ Huang LY Guo X Kong CL Murriel SF Dowdy, BMC Biotechnol 2009 9 40 10.1186/1472-6750-9-40 19393090
31. Recent advances in the use of cell-penetrating peptides for medical and biological applications. SB Fonseca MP Pereira SO Kelley, Adv Drug Deliv Rev 2009 61 953 964 10.1016/j.addr.2009.06.001 19538995
32. Enhancing the cellular uptake of siRNA duplexes following noncovalent packaging with protein transduction domain peptides. BR Meade SF Dowdy JM Gump SF Dowdy BR Meade SF Dowdy X Dong JN Wang YZ Huang LY Guo X Kong CL Murriel SF Dowdy, Adv Drug Deliv Rev 2008 60 530 536 10.1016/j.addr.2007.10.004 18155315
33. Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides. BR Meade SF Dowdy X Dong JN Wang YZ Huang LY Guo X Kong CL Murriel SF Dowdy, Adv Drug Deliv Rev 2007 59 134 140 10.1016/j.addr.2007.03.004 17451840
34. Zinc-finger nucleases as a novel therapeutic strategy for targeting hepatitis b virus DNAs. TJ Cradick K Keck S Bradshaw AC Jamieson AP McCaffrey, Mol Ther 2010 2010 16
35. Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo. N Holt J Wang K Kim G Friedman X Wang V Taupin GM Crooks DB Kohn PD Gregory MC Holmes PM Cannon, Nat Biotech 2010 28 839 847 10.1038/nbt.1663
36. Targeted transgene integration in plant cells using designed zinc finger nucleases. CQ Cai Y Doyon WM Ainley JC Miller RC Dekelver EA Moehle JM Rock YL Lee R Garrison L Schulenberg R Blue A Worden L Baker F Faraji L Zhang MC Holmes EJ Rebar TN Collingwood B Rubin-Wilson PD Gregory FD Urnov JF Petolino, Plant Mol Biol 2009 69 699 709 10.1007/s11103-008-9449-7 19112554
37. Comparison of zinc finger nucleases for use in gene targeting in mammalian cells. SM Pruett-Miller JP Connelly ML Maeder JK Joung MH Porteus, Mol Ther 2008 16 707 717 10.1038/mt.2008.20 18334988
38. Custom-designed zinc finger nucleases: what is next? J Wu K Kandavelou S Chandrasegaran T Mashimo A Takizawa B Voigt K Yoshimi H Hiai T Kuramoto T Serikawa, Cell Mol Life Sci 2007 64 2933 2944 10.1007/s00018-007-7206-8 17763826
39. ZifBASE: a database of zinc finger proteins and associated resources. M Jayakanthan J Muthukumaran S Chandrasekar K Chawla A Punetha D Sundar, BMC Genomics 2009 10 421 10.1186/1471-2164-10-421 19737425
40. Zinc Finger Database (ZiFDB): a repository for information on C2H2 zinc fingers and engineered zinc-finger arrays. F Fu JD Sander M Maeder S Thibodeau-Beganny JK Joung D Dobbs L Miller DF Voytas, Nucleic Acids Res 2009 37 Database 279 283 10.1093/nar/gkn606 18812396
41. Zinc Finger Targeter (ZiFiT): an engineered zinc finger/target site design tool. JD Sander P Zaback JK Joung DF Voytas D Dobbs, Nucleic Acids Res 2007 35 Web Server 599 605 10.1093/nar/gkm349 17526515
42. Zinc Finger Tools: custom DNA-binding domains for transcription factors and nucleases. JG Mandell CF Barbas, Nucleic Acids Res 2006 34 Web Server 516 523 10.1093/nar/gkl209 16845061
43. Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development. K Na-Bangchang J Karbwang, Fundam Clin Pharmacol 2009 23 387 409 10.1111/j.1472-8206.2009.00709.x 19709319
44. The fight against drug-resistant malaria: novel plasmodial targets and antimalarial drugs. SR Choi P Mukherjee MA Avery, Curr Med Chem 2008 15 161 171 10.2174/092986708783330575 18220771
45. Novel molecular targets for antimalarial chemotherapy. S Jana J Paliwal, Int J Antimicrob Agents 2007 30 4 10 10.1016/j.ijantimicag.2007.01.002 17339102
46. Plasmodium falciparum: new molecular targets with potential for antimalarial drug development. DL Gardiner TS Skinner-Adams CL Brown KT Andrews CM Stack JS McCarthy JP Dalton KR Trenholme, Expert Rev Anti Infect Ther 2009 7 1087 1098 10.1586/eri.09.93 19883329
47. Genomics and systems biology in malaria drug discovery. NV Dharia A Chatterjee EA Winzeler, Curr Opin Investig Drugs 11 131 138 20112162
48. Cell-targeting and cell-penetrating peptides for delivery of therapeutic and imaging agents. RL Juliano R Alam V Dixit HM Kang, Wiley Interdiscip Rev Nanomed Nanobiotechnol 2009 1 324 335 10.1002/wnan.4 20049800
49. Cell-penetrating and cell-targeting peptides in drug delivery. E Vives J Schmidt A Pelegrin, Biochim Biophys Acta 2008 1786 126 138 18440319
50. Cell-penetrating peptides: from molecular mechanisms to therapeutics. MC Morris S Deshayes F Heitz G Divita, Biol Cell 2008 100 201 217 10.1042/BC20070116 18341479
51. Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers. VP Torchilin, Adv Drug Deliv Rev 2008 60 548 558 10.1016/j.addr.2007.10.008 18053612
52. Identification of peptides targeting the surface of plasmodium falciparum-infected erythrocytes using a phage display peptide library. K Eda S Eda IW Sherman, Am J Trop Med Hyg 2004 71 190 195 15306709
53. Use of penetrating peptides interacting with PP1/PP2A proteins as a general approach for a drug phosphatase technology. J Guergnon F Dessauge V Dominguez J Viallet S Bonnefoy VJ Yuste O Mercereau-Puijalon X Cayla A Rebollo SA Susin PE Bost A Garcia, Mol Pharmacol 2006 69 1115 1124 10.1124/mol.105. 019364 16387795
54. TAT opens the door. PM Vyas RM Payne, Mol Ther 2008 16 647 648 10.1038/mt.2008.24 18362922
55. Targeted delivery of DNA to the mitochondrial compartment via import sequence-conjugated peptide nucleic acid. A Flierl C Jackson B Cottrell D Murdock P Seibel DC Wallace, Mol Ther 2003 7 550 557 10.1016/S1525-0016(03) 00037-6 12727119
56. Heme biosynthesis by the malarial parasite. Import of delta-aminolevulinate dehydrase from the host red cell. ZQ Bonday S Taketani PD Gupta G Padmanaban ZQ Bonday S Dhanasekaran PN Rangarajan G Padmanaban, J Biol Chem 1997 272 21839 21846 10.1074/jbc.272.35.21839 9268315
57. Import of host delta-aminolevulinate dehydratase into the malarial parasite: identification of a new drug target. ZQ Bonday S Dhanasekaran PN Rangarajan G Padmanaban, Nat Med 2000 6 898 903 10.1038/78659 10932227
58. The malarial parasite Plasmodium falciparum imports the human protein peroxiredoxin 2 for peroxide detoxification. S Koncarevic P Rohrbach M Deponte G Krohne JH Prieto J Yates S Rahlfs K Becker, Proc Natl Acad Sci USA 2009 106 13323 13328 10.1073/pnas.0905387106 19666612
59. A nuclear targeting system in Plasmodium falciparum. K Wittayacom C Uthaipibull K Kumpornsin R Tinikul T Kochakarn P Songprakhon T Chookajorn, Malar J 9 126 10.1186/1475-2875-9-126 20470378
60. Targeting GFP to the malarial mitochondrion. S Sato K Rangachari RJ Wilson, Mol Biochem Parasitol 2003 130 2 155 158 10.1016/S0166-6851(03)00166-X 12946854
61. GFP-targeting allows visualization of the apicoplast throughout the life cycle of live malaria parasites. RR Stanway T Witt B Zobiak M Aepfelbacher VT Heussler, Biol Cell 2009 101 415 430 415 p following 430. 10.1042/BC20080202 19143588
62. Protein targeting to the malaria parasite plastid. CJ Tonkin M Kalanon GI McFadden, Traffic 2008 9 166 175 17900270
63. Evolution of malaria parasite plastid targeting sequences. CJ Tonkin BJ Foth SA Ralph N Struck AF Cowman GI McFadden, Proc Natl Acad Sci USA 2008 105 4781 4785 10.1073/pnas.0707827105 18353992
64. Mitochondria-penetrating peptides. KL Horton KM Stewart SB Fonseca Q Guo SO Kelley, Chem Biol 2008 15 375 382 10.1016/j.chembiol.2008.03.015 18420144
65. Organelle-targeted delivery of biological macromolecules using the protein transduction domain: potential applications for peptide aptamer delivery into the nucleus. T Yoshikawa T Sugita Y Mukai N Yamanada K Nagano H Nabeshi Y Yoshioka S Nakagawa Y Abe H Kamada S Tsunoda Y Tsutsumi, J Mol Biol 2008 380 777 782 10.1016/j.jmb.2008.05.047 18571668
66. Homologous and non-homologous recombination differentially affect DNA damage repair in mice. J Essers H van Steeg J de Wit SM Swagemakers M Vermeij JH Hoeijmakers R Kanaar, Embo J 2000 19 1703 1710 10.1093/emboj/19.7.1703 10747037
67. Homology-directed repair is a major double-strand break repair pathway in mammalian cells. F Liang M Han PJ Romanienko M Jasin, Proc Natl Acad Sci USA 1998 95 5172 5177 10.1073/pnas.95.9.5172 9560248 (Pubitemid 28208570)
68. Pharmacogenomic analyses of targeting the AT-rich malaria parasite genome with AT-specific alkylating drugs. JM Woynarowski M Krugliak H Ginsburg, Molecular and Biochemical Parasitology 2007 154 70 81 10.1016/j.molbiopara.2007. 04.009 17524501
69. Targeted chromosomal deletions in human cells using zinc finger nucleases. HJ Lee E Kim J-S Kim, Genome Research 2010 20 81 89 10.1101/gr.099747.109 19952142
70. Autonomous zinc-finger nuclease pairs for targeted chromosomal deletion. C Sollu K Pars TI Cornu S Thibodeau-Beganny ML Maeder JK Joung R Heilbronn T Cathomen, Nucl Acids Res 2010 gkq720. 20716517
71. An improved and highly sensitive microfluorimetric method for assessing susceptibility of Plasmodium falciparum to antimalarial drugs in vitro. NB Quashie HP de Koning LC Ranford-Cartwright, Malar J 2006 5 95 10.1186/1475-2875-5-95 17076900
72. A novel DNA-based microfluorimetric method to evaluate antimalarial drug activity. Y Corbett L Herrera J Gonzalez L Cubilla TL Capson PD Coley TA Kursar LI Romero E Ortega-Barria, Am J Trop Med Hyg 2004 70 119 124 14993620
73. Efficient gene targeting in Drosophila with zinc-finger nucleases. K Beumer G Bhattacharyya M Bibikova JK Trautman D Carroll, Genetics 2006 172 2391 2403 10.1534/genetics.105.052829 16452139
74. Attenuation of zinc finger nuclease toxicity by small-molecule regulation of protein levels. SM Pruett-Miller DW Reading SN Porter MH Porteus, PLoS Genet 2009 5 1000376 10.1371/journal.pgen.1000376 19214211
75. Quantification of zinc finger nuclease-associated toxicity. TI Cornu T Cathomen, Methods Mol Biol 2010 649 237 245 full-text 20680838
76. A rapid and general assay for monitoring endogenous gene modification. DY Guschin AJ Waite GE Katibah JC Miller MC Holmes EJ Rebar, Meth Mol Biol 2010 649 247 256 full-text